1039455-02-1

Basic information

• Product Name: C₂₁H₁₆FN₅O₄
• Synonyms: C₂₁H₁₆FN₅O₄
• CAS NO: 1039455-02-1
• Molecular Weight: 421.388
• Mol File: 1039455-02-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₁H₁₆FN₅O₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₁H₁₆FN₅O₄(1039455-02-1)
• EPA Substance Registry System: C₂₁H₁₆FN₅O₄(1039455-02-1)

Safety Data

• Hazardous Substances Data: 1039455-02-1(Hazardous Substances Data)

Upstream product

• 5372-81-6 dimethyl aminoterephthalate 
• 1039454-99-3 methyl 7-nitro-5-oxo-2,3-dihydro-5H-[1,3]oxazolo[2,3-b]quinazoline-8-carboxylate 
• 1039455-01-0 C₂₁H₁₅FN₄O₅ 

Downstream Products

• 1039455-03-2 C₂₁H₁₅BrFN₅O₃ 
• 1039453-42-3 3-[(2S)-1-(3-fluorophenyl)but-3-yn-2-yl]-8,9-dihydro-3H-[1,3]oxazolo[2,3-b][1,2,3]triazino[4,5-g]quinazoline-4,11-dione 

Relevant articles and documents

3-SUBSTITUTED-[1,2,3]BENZOTRIAZINONE COMPOUNDS FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES

This invention relates to the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for higher order behaviors. These brain networks are involved in cognitive abilities related to memory impairment, such as is observed in a variety of dementias and in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia and affective disorders. In a particular aspect, the present invention relates to compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.